Sign In
Buy PPH
$110.40
-1.20 (-1.08%)
At Close: Jul 31, 2026
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:31am, Thursday, 04'th Jan 2024
Launched on 12/20/2011, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.
Biotech Stocks Are Rallying, but the Outlook Isn't Good
12:28pm, Wednesday, 15'th Nov 2023
The XBI has been climbing this month. On Tuesday it jumped 5.4% to close at $70.91.
Pharma ETFs in Focus Post Q3 Earnings
12:46pm, Wednesday, 08'th Nov 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:31am, Wednesday, 01'st Nov 2023
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launc
PPH: A 'Shot In The Arm' For Investors Looking To Capitalize On Recent Pharmaceutical Advances
03:35am, Tuesday, 31'st Oct 2023
VanEck Pharmaceutical ETF has had the strongest one-year performance of four major pharmaceutical ETF competitors due to its unique mix of Novo Nordisk, Eli Lilly, and Johnson & Johnson. Eli Lilly, PP
PPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfolio
02:02am, Sunday, 29'th Oct 2023
Eli Lilly is a mega-cap stock in the Health Care sector that has performed well in 2023, and it's the top holding in the VanEck Pharmaceutical ETF. I have a buy rating on the low-cost and style & geog
Disruptive Tech Theme of the Week: Weight Loss Revolution
03:02pm, Monday, 23'rd Oct 2023
According to the latest CDC National Diabetes Statistics Report, more than 37 million people have diabetes in the U.S., or 11.3% of the population. The statistics for obesity are also dismal, as the W
Weight Loss Drugs Could Prove Potent for PPH
10:32am, Monday, 11'th Sep 2023
Ozempic commercials are, at this point, ubiquitous and while that's an anecdotal example, it also represents confirmation that obesity drugs are the next big thing in the pharmaceuticals industry.
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
01:31pm, Wednesday, 30'th Aug 2023
The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market
6 Best-Performing ETFs of Last Week
01:09pm, Monday, 14'th Aug 2023
Wall Street delivered a mixed performance last week.
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
Cautious on Big Tech & AI? Try These Value-Focused Sector ETFs
02:27pm, Wednesday, 09'th Aug 2023
Value-focused investing comes to rescue if high-growth sectors fail for some reasons.
Pharma ETF (PPH) Hit a 52-Week High
08:27am, Wednesday, 09'th Aug 2023
Investors seeking momentum may have VanEck Pharmaceutical ETF PPH on radar now. The fund recently hit a new 52-week high.
PPH: Unnecessary Volatility In A Relatively Stable Healthcare Sector (Technical Analysis)
02:46pm, Monday, 17'th Jul 2023
Pharmaceutical ETFs like PPH may introduce another layer of risk that could be avoided if one took a broader approach to healthcare investing. Technical Analysis displays that beneath the most recent
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:38am, Thursday, 29'th Jun 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund launched on 12/20/2011.
